The Clorox Company $CLX Shares Sold by Integrated Wealth Concepts LLC

Key Points

• Integrated Wealth Concepts LLC reduced its stake in The Clorox Company by 49.7% during Q1, holding 6,918 shares valued at approximately $1,019,000 after selling 6,838 shares.
• JPMorgan Chase & Co. increased its price target for Clorox from $133.00 to $135.00, while Barclays lowered it from $129.00 to $119.00, indicating mixed analyst sentiment towards the stock.
• The Clorox Company announced an increase in its quarterly dividend to $1.24 per share, reflecting a yield of 4.0% with a payout ratio of 76.07%.

Integrated Wealth Concepts LLC decreased its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 49.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,918 shares of the company's stock after selling 6,838 shares during the period. Integrated Wealth Concepts LLC's holdings in Clorox were worth $1,019,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the company. Sonora Investment Management Group LLC lifted its stake in Clorox by 2.5% during the 1st quarter. Sonora Investment Management Group LLC now owns 2,940 shares of the company's stock worth $433,000 after acquiring an additional 72 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in Clorox by 0.6% during the 1st quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,266 shares of the company's stock worth $1,953,000 after acquiring an additional 73 shares in the last quarter. Horizon Investments LLC lifted its stake in Clorox by 4.4% during the 1st quarter. Horizon Investments LLC now owns 1,768 shares of the company's stock worth $258,000 after acquiring an additional 75 shares in the last quarter. Sfmg LLC lifted its stake in Clorox by 2.8% during the 1st quarter. Sfmg LLC now owns 2,780 shares of the company's stock worth $409,000 after acquiring an additional 76 shares in the last quarter. Finally, Hancock Whitney Corp lifted its stake in Clorox by 4.3% during the 1st quarter. Hancock Whitney Corp now owns 2,064 shares of the company's stock worth $304,000 after acquiring an additional 86 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company's stock.

Analyst Ratings Changes

Several brokerages have weighed in on CLX. JPMorgan Chase & Co. upped their price target on Clorox from $133.00 to $135.00 and gave the stock a "neutral" rating in a report on Monday. Barclays cut their price target on Clorox from $129.00 to $119.00 and set an "underweight" rating on the stock in a report on Tuesday, July 15th. Wells Fargo & Company cut their price target on Clorox from $138.00 to $130.00 and set an "equal weight" rating on the stock in a report on Friday, September 5th. Morgan Stanley cut their price target on Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a report on Friday, August 1st. Finally, Jefferies Financial Group cut their price target on Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a report on Thursday, June 26th. One research analyst has rated the stock with a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Reduce" and a consensus target price of $142.18.

Clorox Trading Up 0.9%

CLX opened at $124.44 on Friday. The Clorox Company has a one year low of $116.53 and a one year high of $171.37. The company has a market cap of $15.22 billion, a P/E ratio of 19.09, a PEG ratio of 0.99 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The business's 50-day simple moving average is $124.30 and its 200-day simple moving average is $132.67.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating analysts' consensus estimates of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. During the same quarter in the prior year, the business posted $1.82 EPS. The business's revenue for the quarter was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, equities research analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Wednesday, August 13th were given a $1.24 dividend. This is a boost from Clorox's previous quarterly dividend of $1.22. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.0%. Clorox's payout ratio is currently 76.07%.

Insider Activity

In related news, COO Eric H. Reynolds sold 15,041 shares of the company's stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares of the company's stock, valued at $6,711,475.38. This represents a 21.72% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.57% of the stock is currently owned by company insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.